The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

NCT06160440 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Diopathic Pulmonary Fibrosis
Pulmonary Fibrosis

Interventions

DRUG: SC1011

Sponsor

Guangzhou JOYO Pharma Co., Ltd